- Barclays has increased its price target for MetLife (NYSE:MET), signaling potential upside for the insurance stock.
- MetLife announced a fourth-quarter 2026 dividend of $0.59 per common share.
- The stock price for MetLife is currently trading near its 52-week high, reflecting strong market performance.
MetLife (NYSE:MET), a leading provider of life insurance, annuities, and employee benefits, recently saw its stock price target raised by Barclays. The investment bank increased its outlook for the insurance stock to $111 from $97. It’s important to remember that a price target represents an analyst’s estimate of where a stock could trade, not a guaranteed future price.
At the time the new target was published, MetLife shares were trading at $97.16, approximately 14.2% below the updated target. This significant gap highlights the potential upside implied by Barclays’ optimistic estimate. Today, the stock performance shows shares are up $0.28, or 0.29%, with an intraday trading range between $96.93 and $99.06.
In other significant news for MetLife shareholders, the company also declared a fourth-quarter 2026 dividend of $0.59 per common share, as highlighted by Business Wire. This dividend payment, a direct distribution to shareholders, is scheduled to be paid on December 8, 2026, to shareholders of record as of November 3, 2026.
Analyzing the broader context, MetLife’s 52-week trading range spans from $67.33 to $100.93, positioning its current price near the higher end of this spectrum. The company’s substantial market capitalization, representing the total value of its outstanding shares, is approximately $62.5 billion. Furthermore, today’s trading activity saw approximately 4.3 million shares change hands, indicating active investor interest in the insurance giant.
